Nanobiotix presents early lung cancer trial data at ESTRO

🌐 Investing.com (CY) —
Nanobiotix presents early lung cancer trial data at ESTRO

AI Summary

Nanobiotix has presented early trial data for a new lung cancer treatment at the ESTRO conference, which shows promising results and could pave the way for further investments in innovative cancer therapies. This development highlights the potential of nanotechnology in medicine.

Health AI & Tech lung cancer trial data Nanobiotix ESTRO nanotechnology

Read original source →